Company intelligence / Profile preview

Braasch Biotech LLC

Garretson, South Dakota, United Statesbraaschbiotech.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Braasch Biotech is developing anti-somatostatin vaccines that temporarily reduce the inhibitory actions of somatostatin, allowing more growth hormone to be released. Their JH-17 product is in preclinical stage for obesity treatment. Their technology has shown effectiveness in dairy cows and pigs without negative safety or health issues[3][5].

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Vaccinesspecifically anti-somatostatin vaccines
Industry: Biotech

Beyond the preview

Go deeper on Braasch Biotech LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Braasch Biotech LLC.

Explore the full profile